Lexicon did manage to get approval for type 1 diabetes in Europe, but the product was never launched there for commercial ...

CHEERS-AI – or Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence ...

The NHS often relies on professional interpreters and translation services to bridge these gaps, but this comes at a ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 ...

For the wider therapeutic area, the FDA’s response will act as both a cause for concern and a potential way forward. Those ...

The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to ...

The fine of €462.6 million ($503 million) is believed to be the largest imposed on a pharma company for breaking antitrust ...

The new accelerated approval covers the use of Scemblix for newly diagnosed patients with Philadelphia chromosome-positive ...

If approved, the less burdensome version of Leqembi could be used to treat patients at home or in medical facilities, help ...

Join the ultimate European gathering of microbiome innovators dedicated to translating groundbreaking research into viable, ...

AbbVie has boosted its Alzheimer's disease pipeline with a $1.4 billion cash deal to buy Aliada Therapeutics and its ...

Under the terms of the deal, MSD (known as Merck & Co in the US and Canada) is paying $30 million upfront for Modifi, with up ...